Omeprazole

Active ingredient description

Omeprazole, a racemic mixture of two enantiomers reduces gastric acid secretion through a highly targeted mechanism of action. It is a specific inhibitor of the acid pump in the parietal cell. It is rapidly acting and provides control through reversible inhibition of gastric acid secretion with once daily dosing.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

A02BC01

Omeprazole

A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BC Proton pump inhibitors

Discover more medicines within A02BC01

Medicines

Omeprazole is the active ingredient of these drugs:

ACIMAX

Australia

AGASTIN

Poland

ALTOSEC

South Africa

AMPRA

Hong Kong

ANADIR

Italy

ANTRA

Italy

ANTRA MUPS

Germany

ARAPRIDE

Spain

AULCER

Spain

BELIFAX

Tunisia

BIOPRAZOL

Poland

BYSEC

Ireland

CLETUS

Italy

CORPOCID

South Africa

DOLINTOL

Spain

DUDENCER

Hong Kong

ELPRAZOL

Brazil

EPRAZOLE

Hong Kong

EUPEPT

Brazil

EZIPOL

Cyprus Hong Kong

GASEC

Estonia Hong Kong Lithuania Poland

GASTER

Hong Kong

GASTOM

Hong Kong

GASTRAL

Tunisia

GASTRIMUT

Spain

GAZIGON

South Africa

GOMEC

Hong Kong

GOPRAZOL

Poland

HELICID

Poland

HELIGEN NEO

Poland

IBIMEZOLO

Italy

INHIPEP

Poland

IPPROTON

Tunisia

KOMEZOL

Italy

KRUXAGON

Italy

LICOMEP

Ireland

LIMNOS

Italy

LOKIT

South Africa

LOMAC

Hong Kong

LOMICID

Hong Kong

LOSAMEL

Ireland

LOSCID

Hong Kong

LOSEC

Australia Austria Brazil Canada Cyprus

LOSECOSAN

Netherlands

LOSECTIL

Hong Kong

LOSEPRAZOL

Estonia Poland

LOZEPREL

Brazil

MAALOX CONTROLE

Tunisia

MARICRIO

Italy

MAXOR

Australia

MEDOPRAZOLE

Cyprus

MEPRAL

Italy

MEZZOPRAM

United Kingdom

MOPRAL

France Tunisia

NANSEN

Italy

NEOPRAZOL

Brazil

NEPRAZOL

Brazil

NOCID

Hong Kong

NOGASID

Hong Kong

NOVOPRAZOL

Brazil

NOZER

South Africa

NUCLOSINA

Spain

OCID

Singapore

OFNIMAREX

Cyprus

OLEZELA

Lithuania

OLIT

Singapore

OMAPREN

Spain

OMEBETA

Germany

OMEBOIX

Poland

OMEC HEXAL

Austria

OMECAT

Netherlands

OMECID

Hong Kong

OMEDIN

Hong Kong

OMEDIPROL

Lithuania

OMEFLUX

Estonia

OMEKAA

Hong Kong

OMEKASTE

Spain

OMENAX

Brazil

OMENOLE

Singapore

OMEPRACOTE

South Africa

OMEPRADEX

Singapore

OMEPRAL

Australia

OMEPRALAN

Austria

OMEPRAMED

Brazil

OMEPRAZEN

Italy

OMEPRAZIN

Brazil

OMEPROTECT

Spain

OMESEC

Hong Kong Singapore

OMESTAD

Finland

OMEZ

South Africa

OMEZOL

Hong Kong New Zealand Singapore Tunisia

OMEZOLE

Hong Kong Singapore

OMICAP

Singapore

OMIFLUX

South Africa

OMILOC

South Africa

OMILOCK

Hong Kong

OMIZAC

Hong Kong

OMIZEC

Hong Kong

OMOLIN

Estonia Italy

OMOPREL

Brazil

OMPRANYT

Cyprus

OPRAZOLE

Tunisia

OPRAZON

Brazil

ORTANOL

Poland

OZMEP

Australia

PARIZAC

Spain

PEDIPPI

Ireland Netherlands New Zealand

PEMZO

Australia

PENRAZOL

Cyprus Singapore

PEPTICUM

Spain

POLPRAZOL

Poland

PRATIPRAZOL

Brazil

PRENOME

Poland

PRILOSEC

United States

PROBITOR

Australia New Zealand Singapore South Africa

PROCEPTIN

Singapore

PROGASTIM

Poland

PROMESEC

Singapore

PROTEC

Italy

PUMPITOR

Singapore

PYLORID

Hong Kong

PYROCALM

United Kingdom

RAMEZOL

Singapore

REDUSEC

Hong Kong

REMEPRAZOLE

Cyprus

REMOSTAR

Lithuania

RISEK

Tunisia

ROMESEC

Singapore

SAGALIX

Poland

SOLCER

Singapore

TEUTOZOL

Brazil

TUMSIGON

South Africa

ULCERAL

Spain

ULCESEP

Spain

ULCEZOL

Italy

ULTOP

Estonia Lithuania Poland

ULZAC

Lithuania

VENTAZOL

Poland

VICKOSEC

Hong Kong

VICKSEC

Hong Kong

XANTRAZOL

Estonia

ZENPRO

Hong Kong Singapore

ZIGACAP

Hong Kong

ZIMOR

Singapore

ZOLTUM

France

Omeprazole is also found within below combination drugs:

ARTHROCOMB , CECLOVA , DICLODUO COMBI , DICLOPRAM , DIOMPRAZ , OMEPRAMIX , PROFENID PROTECT , TALICIA , YOSPRALA , ZEGERID

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

OMEPRAZOLE Powder for solution for infusion

Summary of Product Characteristics (SPC)

OMEPRAZOLE Gastro-resistant capsules

Summary of Product Characteristics (SPC)

PRILOSEC Granule for delayed-release oral suspension

Structured Product Labeling (SPL/PLR)

Next: Usage

Omeprazole

Active ingredient description

Medicine classification

Medicines

Product monographs

Structural formula

3D molecular structure

Unique ingredient identifier (UNII)

CAS registry number

SNOMED-CT